Synchron Pauses Brain Implant Trials Over Cable Problem
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
Brain-computer interface company Synchron has stopped enrolling new patients in trials of its second-generation Stentrode implant.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
4 confirmed facts, 2 open questions and 2 sources behind this story.